What is the recommended management for a 2.6 cm left adrenal gland nodule with characteristics suggestive of an adenoma, Hounsfield units (HU) much less than 10, and absolute washout over 70%, in an asymptomatic patient with no signs of hormone overproduction and an unremarkable right adrenal gland?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a 2.6 cm Adrenal Adenoma with Benign Imaging Characteristics

This adrenal mass requires no further imaging follow-up or functional testing, as it meets definitive criteria for a benign non-functional adenoma. 1, 2, 3

Rationale for No Further Follow-Up

Your lesion demonstrates all three hallmark features of a benign lipid-rich adenoma:

  • Hounsfield units <10 on non-contrast CT (the single best criterion for diagnosing benign adenoma) 1
  • Absolute washout >70% (far exceeding the 60% threshold for benignity) 1
  • Size <4 cm (2.6 cm falls well below the threshold requiring surveillance) 1, 2

The Canadian Urological Association (endorsed by the American Urological Association) explicitly states that patients with benign non-functional adenomas <4 cm do not require further follow-up imaging or functional testing. 1 This recommendation is echoed by the American College of Radiology, which confirms that masses <10 HU are definitively benign lipid-rich adenomas requiring no further imaging workup. 2, 3

Critical Size Thresholds

The 4 cm cutoff is evidence-based and consistent across multiple guidelines:

  • **Masses <3 cm**: In patients without cancer history, only 1.5% are malignant, and all malignancies were >5 cm in the largest series 1
  • Masses <4 cm with benign imaging: No surveillance needed 1
  • Masses ≥4 cm: Require repeat imaging in 6-12 months even if radiologically benign 1
  • Masses >5-6 cm: Should be surgically removed due to higher malignancy risk 1

Hormonal Evaluation Considerations

While imaging confirms benignity, approximately 5% of radiologically benign incidentalomas have subclinical hormone production. 2, 3 However, the question states the patient is asymptomatic with no signs of hormone overproduction. If hormonal screening has not been performed, consider one-time testing for:

  • Pheochromocytoma: Plasma or 24-hour urinary metanephrines 1, 3, 4
  • Cortisol excess: 1 mg overnight dexamethasone suppression test 4
  • Aldosterone excess (only if hypertensive or hypokalemic): Aldosterone-to-renin ratio 3, 4

If hormonal workup is negative, no repeat hormonal testing is needed. 1

Common Pitfalls to Avoid

Do not perform adrenal biopsy - it is contraindicated for suspected benign lesions due to unnecessary risks including tumor seeding and potential hypertensive crisis if an undiagnosed pheochromocytoma is present. 1, 2, 3

Do not order repeat imaging - this increases radiation exposure, patient anxiety, and healthcare costs without clinical benefit for masses meeting all benign criteria. 1, 3

Do not pursue annual surveillance - the ESE guidelines specifically recommend against routine follow-up imaging for radiologically benign adenomas <4 cm, as the rate of malignant transformation is 0% to <1%. 1

Why Washout Criteria Support Benignity

Your lesion's absolute washout >70% provides additional confirmation beyond the HU measurement. The standard threshold is ≥60% absolute washout at 15 minutes for adenoma diagnosis. 1 While approximately one-third of adenomas may not washout in the typical range, your lesion exceeds this threshold substantially, further supporting benignity. 1

Documentation and Patient Communication

Document that this represents a benign non-functional adenoma requiring no further follow-up based on definitive imaging criteria. 1 Reassure the patient that these lesions do not transform into malignancy and do not require monitoring. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Imaging and Management of Incidentally Discovered Adrenal Masses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach for Incidental Adrenal Mass

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Preoperative Hormonal Evaluation for Adrenal Tumors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.